{
  "abstract": "Cervical cancer ranks as the fourth most common cancer among women, with the incidence and mortality rates of cervical cancer remaining particularly high in low- and middle-income countries.1 This may be related to factors such as ineffective vaccination programmes and a shortage of skilled, professional cytology personnel.2 3 In many countries, including China, cytopathology as a sub-specialty has not been completely established, and the cytotechnologist career is virtually non-existent. With the development of artificial intelligence (AI) technology, new technological approaches have emerged to improve Pap test screening, which is a critical component of Pap test review, but can be repetitive and labour-intensive. Currently, cervical cytology AI screening systems are divided into two major categories: slide-based AI systems and whole slide imaging (WSI)-based AI systems.",
  "authors": [
    {
      "affiliations": [
        "Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"
      ],
      "name": "Xinru Bai"
    },
    {
      "affiliations": [
        "Department of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, USA"
      ],
      "name": "Terrel Jones"
    },
    {
      "affiliations": [
        "Department of Pathology, UPMC Magee-Womens Hospital, University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, USA"
      ],
      "name": "Chengquan Zhao"
    }
  ],
  "title": "Cutting-edge progress of artificial intelligence in cervical cytology",
  "uid": "ed239929-470a-562e-937f-51bcd953e666"
}